BIOCRYST PHARMACEUTICALS, INC.: revenue
| Value | {"amount": 874837000, "concept": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax", "currency": "USD"} |
|---|---|
| Period | 2025-01-01 – 2025-12-31 |
| Status | current |
| Entity | BIOCRYST PHARMACEUTICALS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T08:48:50.529413+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/ba3b85be-ccc2-461f-ab96-6f2f9389b724
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001628280-26-012240Retrieved: 2026-08-19T08:48:50.529413+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000882796/revenue/2025-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/ba3b85be-ccc2-461f-ab96-6f2f9389b724
History
- no predecessors — first report